Loading
companiesCompany
PathAI
PathAI runs the AISight AI pathology platform and quantifies biomarkers for pharma trials.
Overview
PathAI, based in Boston, runs the AISight AI pathology platform and quantifies biomarkers for pharmaceutical trials. Its products include AISight image management, the AIM-PD-L1 and AIM-HER2 quantification algorithms and TumorDetect, backed by large pharma partnerships, and its PLUTO foundation model has its own OnCo record. OnCo links it to digital pathology and to bottlenecks on unvalidated AI, unstandardised biomarkers and the shortage of pathologists, and to ideas including a standard evaluation pathway for AI pathology and one digital PD-L1 scale that maps across competing assays. Whether AI biomarker scoring becomes the regulatory standard for trial enrolment is the open question. The digital pathology page carries the wider picture.
Similar pages
- CompanyPaige AI
Shares A standard evaluation pathway for AI-assisted pathology, from reader study to deployment, AI second reads to stop borderline lesions being upgraded to cancer, Version control and locked reference sets for AI algorithms used as companion diagnostics, A pre-competitive consortium to train a shared multimodal cancer foundation model.
- IdeaPublic gold-standard datasets for validating every cancer biomarker test
Shares Version control and locked reference sets for AI algorithms used as companion diagnostics, One digital PD-L1 scale that maps across all the competing assays, AI that is built but not validated or deployed, Digital pathology & AI.
- IdeaPathologist assistants plus AI triage to multiply pathologist capacity
Shares AI-first reading for high-volume common cancer diagnoses, pathologist for the exceptions, AI that is built but not validated or deployed, Not enough oncologists, nurses, pathologists, physicists, Digital pathology & AI.
- IdeaAI quantification of HER2-low and HER2-ultralow
Shares A standard evaluation pathway for AI-assisted pathology, from reader study to deployment, Version control and locked reference sets for AI algorithms used as companion diagnostics, AI-first reading for high-volume common cancer diagnoses, pathologist for the exceptions, AI that is built but not validated or deployed.
- CompanyOwkin
Shares A pre-competitive consortium to train a shared multimodal cancer foundation model, AI-first reading for high-volume common cancer diagnoses, pathologist for the exceptions, AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI that is built but not validated or deployed.
- IdeaFederated training of pathology and radiology models across hospitals
Shares A pre-competitive consortium to train a shared multimodal cancer foundation model, AI that is built but not validated or deployed, Digital pathology & AI.
- CompanyArtera
Shares AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI that is built but not validated or deployed, Digital pathology & AI.
- IdeaA registry of external validation datasets for cancer AI models, with mandatory reporting
Shares AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI that is built but not validated or deployed, Digital pathology & AI.
fronts
technologies
roadmaps
ideas
A pre-competitive consortium to train a shared multimodal cancer foundation modelA standard evaluation pathway for AI-assisted pathology, from reader study to deploymentAI second reads to stop borderline lesions being upgraded to cancerAI-first reading for high-volume common cancer diagnoses, pathologist for the exceptionsOne digital PD-L1 scale that maps across all the competing assaysVersion control and locked reference sets for AI algorithms used as companion diagnostics
bottlenecks
Software in use
The software of oncology →Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
PathAI's image management system for diagnostic laboratories, the platform its algorithms are meant to run inside.
PathAIFDA K243391